We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
+2.98%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$463M
AUM Growth
+$31.3M
Cap. Flow
+$93.8M
Cap. Flow %
20.28%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
TRDA icon
Entrada Therapeutics
TRDA
+$107M

Top Sells

Rank Stock Value
1
ITOS
iTeos Therapeutics
ITOS
+$13.5M
2
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
+$22

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITOS
1
DELISTED
iTeos Therapeutics
ITOS
$134M 29.03%
2,885,470
-405,241
-12% -$13.5M
TRDA icon
2
Entrada Therapeutics
TRDA
$278M
$75.8M 16.37%
+4,425,784
New +$107M
DYN icon
3
Dyne Therapeutics
DYN
$4.53B
$58.9M 12.72%
4,951,303
– –
HOWL icon
4
Werewolf Therapeutics
HOWL
$47M
$51M 11.03%
4,284,172
– –
RPTX
5
DELISTED
Repare Therapeutics
RPTX
$47.3M 10.22%
2,242,636
– –
AMYT
6
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$28.8M 6.23%
2,668,843
-2
-0% -$22
HARP
7
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$23.6M 5.11%
313,139
– –
TCRR
8
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$18.9M 4.08%
4,050,865
– –
ONCR
9
DELISTED
Oncorus, Inc.
ONCR
$15M 3.25%
2,849,464
– –
RYTM icon
10
Rhythm Pharmaceuticals
RYTM
$7.07B
$9.07M 1.96%
909,258
– –

Similar funds

WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

MPM Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, MPM Asset Management held 10 positions worth $463M, up 7.2% from $431M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

MPM Asset Management deployed $93.8M of net new capital in Q4 2021, opening 1 new position. Its largest new stake was Entrada Therapeutics: 4,425,784 shares worth $75.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was iTeos Therapeutics, an estimated $13.5M trimmed.

  • MPM Asset Management's largest Q4 2021 buy was Entrada Therapeutics: 4,425,784 shares worth $75.8M.
  • MPM Asset Management's biggest Q4 2021 reduction was iTeos Therapeutics, cutting an estimated $13.5M.
  • MPM Asset Management's ten largest holdings make up 100% of its $463M portfolio in Q4 2021.
  • MPM Asset Management opened 1 new position and closed 0 in Q4 2021.
  • MPM Asset Management's portfolio value rose 7.2% quarter-over-quarter to $463M.

Based on MPM Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.